Scenic Biotech
PrivateLast Round
Series A
Mar 10, 2022
Total Funding Raised
$48.95M
Company Overview
Scenic Biotech is a biotechnology company that develops modifier therapies to treat genetic disorders by identifying genes that suppress disease-causing mutations.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scenic Biotech Comparables
Compare Scenic Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Myllia Biotechnology | 86% | |
| Nucleome Therapeutics | 82% | |
| Enhanced Genomics | 79% | |
Scenic Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 10, 2022 | ||||
| Grant | Jun 23, 2020 | ||||
| Series A | Jun 5, 2017 | ||||
| Seed | May 6, 2017 |
Scenic Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMedPartners | Series A |
| Oxford Science Enterprises | Seed, Series A |
| Eir Ventures | Series A |
| Vesalius Biocapital Partners | Series A |
| Oxford Science Enterprises | Series A |
| Inkef Capital | Series A, Seed |
| BioGeneration Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Partnered with Ono Pharmaceutical for novel therapeutic target discovery.
- Oct 27, 2025
Partnered with Secarna Pharmaceuticals to develop novel therapies for genetic diseases.
Scenic Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Scenic Biotech's valuation, stock price, and market status.